Back

A cost-consequence analysis comparing three distinct cardiac ablation strategies for the treatment of paroxysmal atrial fibrillation

1 September 2024 (18:00 - 18:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular health: from autoantibodies to healthcare utilisation Health Economics ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Mileen van de Kar

Catharina Hospital, Eindhoven (Netherlands (The))

8 More presentations in this session

Presentation thumbnail
Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals, cardiovascular and liver diseases in the general population
Professor N. Vuilleumier (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Quality of life in atrial fibrillation patients and its relationship to family member anxiety and depression
Ms L. Tao (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Direct annual healthcare costs in survivors of acute pulmonary embolism: estimates based on a prospective multicentre cohort study
Miss K. Mohr (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
The association between the dietary salt intake and glucose intolerance in the non-diabetic populations: from the Korean National Health and Nutritional Examination Survey (KNHANES)
Mr S. Park (Seoul, KR) Ms S. Hyun (Seoul, KR)
Abstract Slides
Presentation thumbnail
The Waiting 4 Surgery study: burden of in-hospital care
Doctor I. Gomes Campos (Penafiel, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular health: from autoantibodies to healthcare utilisation

The Event

Event poster

ESC Congress 2024

1 September 2024 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of clinical efficacy of pulsed field ablation and second-generation cryoballoon ablation in the treatment of paroxysmal atrial fibrillation
thumbnail
Congress Presentation
BEAT PAROX AF: a randomized comparison of PFA vs RFA
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources